DK1018341T3 - Antistressmidler og funktionelle födevarer - Google Patents

Antistressmidler og funktionelle födevarer

Info

Publication number
DK1018341T3
DK1018341T3 DK98901519T DK98901519T DK1018341T3 DK 1018341 T3 DK1018341 T3 DK 1018341T3 DK 98901519 T DK98901519 T DK 98901519T DK 98901519 T DK98901519 T DK 98901519T DK 1018341 T3 DK1018341 T3 DK 1018341T3
Authority
DK
Denmark
Prior art keywords
pro
functional foods
agents
stress agents
antistress
Prior art date
Application number
DK98901519T
Other languages
Danish (da)
English (en)
Inventor
Akihiro Masuyama
Toshiaki Takano
Original Assignee
Calpis Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Calpis Co Ltd filed Critical Calpis Co Ltd
Application granted granted Critical
Publication of DK1018341T3 publication Critical patent/DK1018341T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55Protease inhibitors
    • A61K38/556Angiotensin converting enzyme inhibitors
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/18Peptides; Protein hydrolysates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06Tripeptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Food Science & Technology (AREA)
  • Vascular Medicine (AREA)
  • Polymers & Plastics (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Psychiatry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Dairy Products (AREA)
  • Peptides Or Proteins (AREA)
  • Confectionery (AREA)
DK98901519T 1997-09-26 1998-02-05 Antistressmidler og funktionelle födevarer DK1018341T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP26242297A JP4727770B2 (ja) 1997-09-26 1997-09-26 尿中カテコールアミン低下、尿中ノルアドレナリン低下、尿中ドーパミン低下及びFischer比低下の少なくとも1つの軽減剤
PCT/JP1998/000480 WO1999016461A1 (fr) 1997-09-26 1998-02-05 Agents antistress et aliments fonctionnels

Publications (1)

Publication Number Publication Date
DK1018341T3 true DK1018341T3 (da) 2004-07-26

Family

ID=17375571

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98901519T DK1018341T3 (da) 1997-09-26 1998-02-05 Antistressmidler og funktionelle födevarer

Country Status (23)

Country Link
US (1) US6410685B1 (fi)
EP (1) EP1018341B1 (fi)
JP (1) JP4727770B2 (fi)
KR (2) KR100383492B1 (fi)
CN (1) CN1198641C (fi)
AT (1) ATE264687T1 (fi)
AU (1) AU728565B2 (fi)
BG (1) BG64692B1 (fi)
BR (1) BR9813222A (fi)
CA (1) CA2303810C (fi)
CZ (1) CZ298848B6 (fi)
DE (1) DE69823369T2 (fi)
DK (1) DK1018341T3 (fi)
ES (1) ES2219868T3 (fi)
HU (1) HUP0004617A3 (fi)
ID (1) ID25635A (fi)
IN (1) IN190794B (fi)
PL (1) PL192873B1 (fi)
PT (1) PT1018341E (fi)
SK (1) SK285148B6 (fi)
TR (1) TR200000863T2 (fi)
TW (1) TWI231213B (fi)
WO (1) WO1999016461A1 (fi)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ334627A (en) * 1999-03-12 2002-07-26 Horticulture & Food Res Inst A therapeutic composition containing a therapeutic agent such as an anthelmintic and an antistress agent such as metyrapone or a nitric oxide promoter for increasing efficacy of therapeutic agents and animal growth
FR2793257B1 (fr) * 1999-05-06 2001-07-27 Gervais Danone Sa Bacteries lactiques a proprietes anxiolytiques, et leurs utilisations
FI113741B (fi) * 1999-11-01 2004-06-15 Valio Oy Menetelmä verenpainetta alentavia peptidejä sisältävän tuotteen valmistamiseksi
JP4633876B2 (ja) * 1999-11-11 2011-02-16 カルピス株式会社 トリペプチドの製造方法
US7892586B2 (en) 2001-02-22 2011-02-22 Suzanne Jaffe Stillman Water containing soluble fiber
US8178150B2 (en) 2000-02-22 2012-05-15 Suzanne Jaffe Stillman Water containing soluble fiber
DE10105040A1 (de) 2001-02-05 2002-08-14 Tell Pharm Ag Hergiswil Tripeptid-Derivate für die Behandlung von postläsionalen Krankheiten des Nervensystems
DE10105038B4 (de) 2001-02-05 2005-07-07 Neurotell Ag Tripeptid-Derivate für die Behandlung von postläsionalen Krankheiten des Nervensystems
DE10105041A1 (de) * 2001-02-05 2002-08-14 Tell Pharm Ag Hergiswil Tripeptide und Tripeptid-Derivate für die Behandlung neurodegenerativer Krankheiten
US20050256057A1 (en) 2002-06-04 2005-11-17 Luppo Edens Protein hydrolysate rich in tripeptides
JPWO2004026296A1 (ja) * 2002-09-18 2006-01-12 味の素株式会社 抗ストレス性疾患組成物
US20050222263A1 (en) * 2002-09-18 2005-10-06 Ajinomoto Co., Inc. Compositions against stress-related diseases and methods for treating stress-related diseases
TWI328457B (en) 2003-03-18 2010-08-11 Suntory Holdings Ltd Angiotensin-converting enzyme inhibitory peptides
AU2004237455B2 (en) * 2003-05-05 2007-08-02 Dsm Ip Assets B.V. Hydrolysed casein product comprising tripeptides IPP and/ or VPP
JP2007529206A (ja) * 2004-03-19 2007-10-25 カンピーナ ネーダーランド ホールディング ビー.ブイ. アンジオテンシン−i−変換酵素阻害特性を有する食品成分及び食品の調製方法、並びにその方法により得られる製品
AU2005261652A1 (en) * 2004-07-12 2006-01-19 Dsm Ip Assets B.V. Blood pressure lowering oligopeptides
ES2599859T3 (es) * 2005-02-24 2017-02-03 Dsm Ip Assets B.V. Proceso enzimático para producir I-P-P a partir de caseína kappa
JP5681341B2 (ja) * 2005-07-26 2015-03-04 カルピス株式会社 発酵乳の製造方法及び発酵乳飲食品
WO2007079977A2 (en) * 2006-01-16 2007-07-19 Dsm Ip Assets B.V. Nutraceutical compositions comprising tripeptides
CN101443031A (zh) * 2006-05-15 2009-05-27 瓦利奥有限公司 治疗用肽的新应用
JP5394628B2 (ja) * 2007-02-09 2014-01-22 クロスフィールドバイオ株式会社 新規なラクトバチルス属微生物および乳酸菌製剤
JP2011504464A (ja) * 2007-11-14 2011-02-10 ディーエスエム アイピー アセッツ ビー.ブイ. 新規血圧降下組成物
JP5618395B2 (ja) * 2009-08-13 2014-11-05 カルピス株式会社 自律神経活動調節用組成物および自律神経を調節する方法
JP2011136932A (ja) * 2009-12-28 2011-07-14 Calpis Co Ltd 脳機能改善用組成物および脳機能を改善する方法
JP2010183918A (ja) * 2010-06-01 2010-08-26 Calpis Co Ltd トリペプチドの製造方法
CN102399261B (zh) * 2010-09-07 2014-06-25 任发政 具有血管紧张素转化酶c-端选择性抑制活性的三肽及其应用和组合物
JP2011102331A (ja) * 2011-02-17 2011-05-26 Calpis Co Ltd 尿中ドーパミン低下の予防及び軽減剤
JP5892687B2 (ja) 2011-07-07 2016-03-23 高砂香料工業株式会社 風味改善ペプチド
CN103204909B (zh) * 2013-04-17 2014-09-03 苏州凯祥生物科技有限公司 一种抗高血压活性肽vppipp
JP5853326B2 (ja) * 2013-12-24 2016-02-09 カルピス株式会社 自律神経活動調節用組成物および自律神経を調節する方法
JP2014208702A (ja) * 2014-07-31 2014-11-06 カルピス株式会社 自律神経活動調節用組成物および自律神経を調節する方法
CN104725485B (zh) * 2014-11-19 2018-01-16 扬州大学 一种重组活性肽及其同步制备方法
WO2017057319A1 (ja) * 2015-09-30 2017-04-06 株式会社明治 乳酸菌スターターの調製方法及び発酵乳の製造方法
CN111909978B (zh) * 2020-07-10 2021-06-22 青岛农业大学 一种利用发酵法从玉米蛋白粉中定向制备富含lpp水解物的方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5189064A (en) * 1985-07-22 1993-02-23 Matrix Technologies, Inc. Treatment of cocaine addiction
GB2227658A (en) * 1989-02-03 1990-08-08 Cellana Thyrotropin releasing hormone (trh) composition for enhancing immune function
IE70080B1 (en) * 1989-02-16 1996-10-30 Sankyo Co Peptides having renin inhibitory activity their preparation and use
US5593967A (en) * 1990-08-31 1997-01-14 Warner-Lambert Company Cholecystokinin antagonists, their preparation and therapeutic use
US5264419A (en) * 1990-08-31 1993-11-23 Warner-Lambert Company N-substituted cycloalkyl and polycycloalkyl α-substituted TRP derivatives
JP2904655B2 (ja) * 1992-09-17 1999-06-14 サントリー株式会社 抗ストレス剤
US5639729A (en) * 1993-08-26 1997-06-17 Immunobiology Research Institute, Inc. Tripeptides useful in immune and CNS therapy
US5604198A (en) * 1994-05-12 1997-02-18 Poduslo; Joseph F. Method to enhance permeability of the blood/brain blood/nerve barriers to therapeutic agents
JPH08275752A (ja) * 1995-04-07 1996-10-22 Riken Vitamin Co Ltd ストレス改善食品
JPH0920660A (ja) * 1995-07-04 1997-01-21 Suntory Ltd 抗ストレス組成物
JP4065038B2 (ja) * 1996-08-07 2008-03-19 カルピス株式会社 計算作業負荷ストレス緩和剤

Also Published As

Publication number Publication date
TWI231213B (en) 2005-04-21
US6410685B1 (en) 2002-06-25
ES2219868T3 (es) 2004-12-01
BR9813222A (pt) 2000-08-29
AU728565B2 (en) 2001-01-11
CA2303810A1 (en) 1999-04-08
KR100379819B1 (ko) 2003-04-14
HUP0004617A3 (en) 2001-11-28
TR200000863T2 (tr) 2000-11-21
WO1999016461A1 (fr) 1999-04-08
ID25635A (id) 2000-10-19
KR20010024277A (ko) 2001-03-26
EP1018341A1 (en) 2000-07-12
KR20030005137A (ko) 2003-01-15
PL339348A1 (en) 2000-12-18
EP1018341A4 (en) 2002-08-28
ATE264687T1 (de) 2004-05-15
BG64692B1 (bg) 2005-12-30
SK285148B6 (sk) 2006-07-07
CZ298848B6 (cs) 2008-02-27
CN1198641C (zh) 2005-04-27
PL192873B1 (pl) 2006-12-29
SK4362000A3 (en) 2001-03-12
PT1018341E (pt) 2004-08-31
JP4727770B2 (ja) 2011-07-20
CA2303810C (en) 2007-03-27
AU5780198A (en) 1999-04-23
CZ20001083A3 (cs) 2001-01-17
CN1279614A (zh) 2001-01-10
JPH11100328A (ja) 1999-04-13
KR100383492B1 (ko) 2003-05-12
IN190794B (fi) 2003-08-23
EP1018341B1 (en) 2004-04-21
DE69823369T2 (de) 2005-05-04
HUP0004617A2 (hu) 2001-05-28
DE69823369D1 (de) 2004-05-27
BG104381A (en) 2001-02-28

Similar Documents

Publication Publication Date Title
DK1018341T3 (da) Antistressmidler og funktionelle födevarer
CA2223510A1 (en) Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease
EP0966969A4 (en) ANTI-STRESS ACTIVE AND FUNCTIONAL NUTRIENTS WITH ANTI-STRESS EFFECTS
ES2095926T5 (es) Cyclosporins.
BR9507752A (pt) Cepas de lactobacilos de origem humanan suas composições e seus usos
WO2003051313A3 (en) Prevention and treatment of oxidative stress disorders by glutathione and phase ii detoxification enzymes
DE60119784D1 (de) Cyclische salen metall verbindungen als einfänger von sauerstoffradikalen und verwendbar als antioxidantien bei der behandlung und vorbeugung von krankheiten
GB2288732B (en) Pharmaceutical compositions
EP1767197A3 (en) Treatment of Alzheimer's disease with inhibitors of cell cycle re-entry and progression
IT1312377B1 (it) Composizioni a base di acido tiottico, cisteina e/o n-acetil cisteinada utilizzarsi in preparazioni farmaceutiche, dietetiche e cosmetiche
TR200003736T2 (tr) Anksiyete durumlarına ya da depresyona bağlı değişikliklerin önlenmesi
NO970533D0 (no) Blodbehandlingssystem og fremgangsmåte som overvåker citratretur til giveren
NO20006646L (no) Aminosyrederivater og legemidler inneholdende de samme som aktiv bestanddel
DE60023657D1 (de) Inhibitore der verzweigte-aminosäure-abhängigen aminotransferase und deren verwendung in der behandlung der zuckerkranke retinopathie
ATE44852T1 (de) Mikrobizide.
EP1690869A4 (en) A PEPTIDE INHIBITING ANGIONTENSIN CONVERTING ENZYME
NO20001196L (no) Nootropisk middel
DE69902879D1 (de) Pflanzliches antivirales mittel
TW200637542A (en) Lipase inhibitor, preventing and treating agent of skin disease
DK0722325T3 (da) Præparat til behandling eller forebyggelse af herpes
TH42734A (th) สารต้านความเครียดและอาหารที่ทำหน้าที่
RU2000104127A (ru) Штамм bacillus subtilis x-15, используемый для профилактики и лечения эндометритов у коров
NO971854D0 (no) Dietmatvarer og farmasöytiske preparater som inhiberer blodkoagulasjon
DE69626307D1 (de) Inhibitor von stickstoffmonoxid (no) synthase zur verhütung von typ ii diabetes
Park Inhibition of Korean radish peroxidase by sodium azide